I know. paid research and all. That being said, they're still interesting to read even if you can totally discard their valuation.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025